Eric Berlizon joined The Company of the Eiffel Tower as the Chief financial officer
The Société de la Tour Eiffel announces the hiring of Eric Berlizon as Chief financial officer in the context of the strengthening of its organization and the rise
AutoVisual up to 1.5 million euros with the Group the Argus
The startup, expert in the big data car, to conduct a fund-raising of 1.5 million euros from the Group’s Argus, a reference to the valuation automotive Download the
Mauna Kea Technologies invited to present at the JMP Securities 2017 Life Sciences Conference
Paris and Boston, June 14, 2017 – 17: 45 – Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY), inventor of Cellvizio®, the platform’s multidisciplinary confocal laser endomicroscopy (CLE), announced
DARE Immunotherapeutics_ Results of the mixed general Meeting of 14 June 2017
Nantes, 14 June 2017, 18 hours – OSE Immunotherapeutics AG (ISIN: FR0012127173; Mnémo: OSE), announces that the annual general Meeting held this day approved all resolutions proposed by
Results of dose escalation of IPH4102 : safety Profile and clinical activity are promising
The part in the dose escalation of the Phase I trial has been the subject of an oral presentation at ICML [1] in Lugano ; Download the free
The winners of We Law You The first contest proposed by a firm of lawyers to destination d…
In partnership with many incubators, DS has created the first contest proposed by a firm of lawyers to destination for start ups. Elected by a prestigious jury, start-ups
Prodways Group, subsidiary of Groupe Gorgé, announces new technology Rapid Additive Forging …
On the eve of the International exhibition of Aeronautics and Space (SIAE) Paris-Le Bourget, Prodways Group, subsidiary of Groupe Gorgé, announces new RAF Technology (Rapid Additive Forging) for
ADLPartner confirms its eligibility for PEA-PME
ADLPartner renews its eligibility to the device PEA-PME for the coming twelve months in accordance with the implementing decree of 4 march 2014 (decree n°2014-283). The eligibility criteria
The Pr. Jamal Tazi, inventor of ABX464, drug candidate the most advanced of ABIVAX, to undue…
Paris, June 15, 2017 at 8: 00 a.m. (CEST) – ABIVAX (Euronext Paris : FR0012333284 – ABVX), a biotechnology company targeting the immune system to eliminate viral diseases
The Group Prunay invests in the start-up Sky inLab
In the framework of its development strategy, the Group Prunay and its subsidiary Maisoning invest in innovative companies judged to be at high potential and whose solutions complement